Terms: = Skin cancer AND TCL1A, P56279, 8115, ENSG00000100721, TCL1 AND Prognosis
12 results:
1. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Jain A; Sweet K
J Natl Compr Canc Netw; 2023 May; 21(5):515-521. PubMed ID: 37156483
[TBL] [Abstract] [Full Text] [Related]
2. [Blastic plasmacytoid dendritic cell neoplasm: A clinico-pathological retrospective analysis of thirteen cases].
Nong L; Wang W; Liang L; Li D; Li X; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):308-314. PubMed ID: 37042142
[TBL] [Abstract] [Full Text] [Related]
3. Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia.
Rose A; Zhang L; Jain AG; Poovathukaran Babu A; Sokol L; Saeed H; Mo Q; Fan W; Zhang X
Am J Hematol; 2023 Jun; 98(6):913-921. PubMed ID: 36964941
[TBL] [Abstract] [Full Text] [Related]
4. Diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review.
Wang Y; Xiao L; Yin L; Zhou L; Deng Y; Deng H
Medicine (Baltimore); 2023 Feb; 102(7):e32904. PubMed ID: 36800625
[TBL] [Abstract] [Full Text] [Related]
5. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
Wilson NR; Konopleva M; Khoury JD; Pemmaraju N
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological analysis of 46 cases with CD4
Suzuki Y; Kato S; Kohno K; Satou A; Eladl AE; Asano N; Kono M; Kato Y; Taniwaki M; Akiyama M; Nakamura S
Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410
[TBL] [Abstract] [Full Text] [Related]
7. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
[TBL] [Abstract] [Full Text] [Related]
8. Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients.
Julia F; Dalle S; Duru G; Balme B; Vergier B; Ortonne N; Vignon-Pennamen MD; Costes-Martineau V; Lamant L; Dalac S; Delattre C; Déchelotte P; Courville P; Carlotti A; De Muret A; Fraitag S; Levy A; Mitchell A; Petrella T
Am J Surg Pathol; 2014 May; 38(5):673-80. PubMed ID: 24441662
[TBL] [Abstract] [Full Text] [Related]
9. Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation.
Kharfan-Dabaja MA; Lazarus HM; Nishihori T; Mahfouz RA; Hamadani M
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1006-12. PubMed ID: 23396213
[TBL] [Abstract] [Full Text] [Related]
10. How I treat prolymphocytic leukemia.
Dearden C
Blood; 2012 Jul; 120(3):538-51. PubMed ID: 22649104
[TBL] [Abstract] [Full Text] [Related]
11. CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
Leitenberger JJ; Berthelot CN; Polder KD; Pro B; McLaughlin P; Jones D; Duvic M
J Am Acad Dermatol; 2008 Mar; 58(3):480-4. PubMed ID: 18280345
[TBL] [Abstract] [Full Text] [Related]
12. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders.
Vermi W; Facchetti F; Rosati S; Vergoni F; Rossi E; Festa S; Remotti D; Grigolato P; Massarelli G; Frizzera G
Am J Surg Pathol; 2004 May; 28(5):585-95. PubMed ID: 15105645
[TBL] [Abstract] [Full Text] [Related]